search
Back to results

Investigating Fitness Interventions in the Elderly (INFINITE) (INFINITE)

Primary Purpose

Obesity, Older Adults, Sedentary

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise Only
Exercise + Diet
Exercise + Diet
Sponsored by
Wake Forest University Health Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring obesity, exercise, intensity, weight loss, diet

Eligibility Criteria

65 Years - 80 Years (Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • BMI=30-34.9 kg/m2
  • Sedentary for past 6 months (<30 min, 3 d/wk of exercise, including walking)
  • Normal cognitive function (MMSE >24)
  • No contraindications for participation in weight loss or exercise (e.g., severe arthritis or musculoskeletal disorders)
  • Able to provide own transportation to study visits and intervention
  • No drug abuse or excessive alcohol use (> 7 drinks/week)
  • Not dependent on a cane or walker

Exclusion Criteria:

  • Weight loss or gain (±5%) in past 6 months
  • Body weight >136.4 kg (DXA limit is 300 lbs)
  • Smoker (No nicotine within past year)
  • Osteoporosis (T-score ≥ -2.5)
  • Abnormal kidney function tests
  • Insulin-dependent or uncontrolled diabetes
  • Uncontrolled hypertension (BP>200/110 mmHg)
  • Hypertriglyceridemia (TG>400 mg/dl)
  • Past or current ischemic heart disease, angina, heart failure, peripheral artery disease, stroke, chronic respiratory disease, uncontrolled endocrine/metabolic disease, neurological or hematological disease, clinically evident edema
  • Cancer requiring treatment in past 2 years, except non-melanoma skin cancers
  • Severe anemia (Hb<10 g/100 ml)
  • Hip fracture, hip or knee replacement, or spinal surgery in past 6 months
  • Regular use of medications that influence study variables (growth/steroid hormones, estrogen, anti-inflammatory, beta blockers, etc.

Sites / Locations

  • Wake Forest University

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Experimental

Experimental

Arm Label

Exercise

Exercise + Diet (-250 kcal/d deficit)

Exercise + Diet (-600 kcal/d deficit)

Arm Description

All treatment groups will receive 4d/wk of exercise

Exercise 4d/wk with moderate caloric restriction (-250 kcal/d deficit) designed for low fat loss (EX+Low CR; ~4.5 kg weight loss),

Exercise 4d/wk with intensive caloric restriction (-600 kcal/d deficit) designed for high fat loss (EX+High CR; ~10.9 kg weight loss)

Outcomes

Primary Outcome Measures

maximal aerobic capacity (VO2max) and functional endurance (400 m walk time)

Secondary Outcome Measures

changes in specific CVD risk factors (inflammatory markers, blood lipids, blood pressure, and glucose tolerance)

Full Information

First Posted
January 11, 2010
Last Updated
July 30, 2018
Sponsor
Wake Forest University Health Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT01048736
Brief Title
Investigating Fitness Interventions in the Elderly (INFINITE)
Acronym
INFINITE
Official Title
Investigating Fitness Interventions in the Elderly (INFINITE)
Study Type
Interventional

2. Study Status

Record Verification Date
July 2018
Overall Recruitment Status
Completed
Study Start Date
October 2009 (undefined)
Primary Completion Date
September 2014 (Actual)
Study Completion Date
September 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Wake Forest University Health Sciences

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Aging is associated with declines in aerobic capacity, exercise tolerance, and functional endurance that lead to physical disability and loss of independence. Furthermore, the existing high prevalence of obesity in the elderly is greatly exacerbating these aging-related declines in function. To date, regular exercise is the only known therapy to consistently improve aerobic function, and perhaps delay the onset of disability. Although aerobic exercise training does benefit both aerobic capacity and endurance even in obese persons, some data show that the maximal efficacy of exercise for improving aerobic function is blunted by obesity. In addition, our preliminary data show a potential dose-response benefit of concomitant fat loss on exercise-induced improvements in aerobic function. Thus, combining an exercise intervention with caloric restriction resulting in fat loss may be more efficacious for improving aerobic function than exercise alone in obese elderly, a population at high risk for disability. The purpose of this study is to determine whether the amount of fat loss (achieved through controlled underfeeding) affects the magnitude of improvement in aerobic function (maximal aerobic capacity and endurance) in response to a standardized exercise training stimulus that follows current recommendations for older persons.
Detailed Description
Design Overview: Phase 1 involves recruitment and screening followed by baseline research testing (Phase 2). Next, subjects will be randomly assigned to one of three 5-month treatments (Phase 3): exercise and high-caloric restriction diet, exercise and low-caloric restriction diet, or exercise only. Subjects will complete follow-up testing after their 5 month intervention. Interventions: Dietary interventions: All participants will be randomly assigned to an exercise intervention with either no dietary intervention (EX Only), or 1 of 2 hypocaloric controlled diets: 1) -250 kcal/day deficit for low fat loss (EX+LOW CR) or 2) -600 kcal/day deficit for high fat loss (EX+HIGH CR) for 20 weeks. All meals are prepared individually after participants choose from a hypocaloric menu designed by the RD to provide a balanced, healthy diet. The calorie level assigned for each person will provide him/her with an absolute daily caloric deficit consistent with their group assignment (-600 or -250 kcals/day). Individual calorie levels will be prescribed to provide calorie levels to the nearest 50 kcals (e.g., 1100 kcal, 1150 kcal, 1200 kcal, etc.). They are educated by the GCRC RDs and provided menus to guide their food purchasing and preparation of daily breakfast meals that are consistent with the prescribed calorie level. They are asked to consume only the food that is given to them or that is approved from the breakfast menu. All participants will pick up their food 3 times/wk during the intervention, and are asked to keep a log of everything they eat or drink. Exercise intervention: The exercise will take place in an exercise facility at the Geriatric Research Center on the campus of the Wake Forest University/Baptist Medical Center. Two study personnel, including at least one trained technician, will supervise all exercise sessions. Emergency equipment will be kept on site during exercise sessions. Blood pressure and heart rate (HR) will be measured before each exercise session and subjects will warm-up by walking for 3-5 min at a slow pace and will then walk at an intensity of 65-70% of heart rate reserve (HRR, assessed during the VO2max test). The duration of walking exercise will progress from 15-20 mins at 50% HRR the 1st week to 30 mins at 65-70% HRR by the end of the 6th week and thereafter. Each walking session will end with a 3-5 min cool-down followed by 5 min of large muscle flexibility exercise.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Older Adults, Sedentary
Keywords
obesity, exercise, intensity, weight loss, diet

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
180 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Exercise
Arm Type
Active Comparator
Arm Description
All treatment groups will receive 4d/wk of exercise
Arm Title
Exercise + Diet (-250 kcal/d deficit)
Arm Type
Experimental
Arm Description
Exercise 4d/wk with moderate caloric restriction (-250 kcal/d deficit) designed for low fat loss (EX+Low CR; ~4.5 kg weight loss),
Arm Title
Exercise + Diet (-600 kcal/d deficit)
Arm Type
Experimental
Arm Description
Exercise 4d/wk with intensive caloric restriction (-600 kcal/d deficit) designed for high fat loss (EX+High CR; ~10.9 kg weight loss)
Intervention Type
Behavioral
Intervention Name(s)
Exercise Only
Other Intervention Name(s)
EX
Intervention Description
4 d/wk of aerobic exercise
Intervention Type
Behavioral
Intervention Name(s)
Exercise + Diet
Other Intervention Name(s)
EX+Low CR
Intervention Description
Exercise 4d/wk with moderate caloric restriction (-250 kcal/d deficit) designed for low fat loss (EX+Low CR; ~4.5 kg weight loss).
Intervention Type
Behavioral
Intervention Name(s)
Exercise + Diet
Other Intervention Name(s)
EX+ High CR
Intervention Description
Exercise 4d/wk with intensive caloric restriction (-600 kcal/d deficit) designed for high fat loss (EX+High CR; ~10.9 kg weight loss)
Primary Outcome Measure Information:
Title
maximal aerobic capacity (VO2max) and functional endurance (400 m walk time)
Time Frame
assessment visits will take place at baseline and post 5 months intervention
Secondary Outcome Measure Information:
Title
changes in specific CVD risk factors (inflammatory markers, blood lipids, blood pressure, and glucose tolerance)
Time Frame
baseline and 5-month follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: BMI=30-34.9 kg/m2 Sedentary for past 6 months (<30 min, 3 d/wk of exercise, including walking) Normal cognitive function (MMSE >24) No contraindications for participation in weight loss or exercise (e.g., severe arthritis or musculoskeletal disorders) Able to provide own transportation to study visits and intervention No drug abuse or excessive alcohol use (> 7 drinks/week) Not dependent on a cane or walker Exclusion Criteria: Weight loss or gain (±5%) in past 6 months Body weight >136.4 kg (DXA limit is 300 lbs) Smoker (No nicotine within past year) Osteoporosis (T-score ≥ -2.5) Abnormal kidney function tests Insulin-dependent or uncontrolled diabetes Uncontrolled hypertension (BP>200/110 mmHg) Hypertriglyceridemia (TG>400 mg/dl) Past or current ischemic heart disease, angina, heart failure, peripheral artery disease, stroke, chronic respiratory disease, uncontrolled endocrine/metabolic disease, neurological or hematological disease, clinically evident edema Cancer requiring treatment in past 2 years, except non-melanoma skin cancers Severe anemia (Hb<10 g/100 ml) Hip fracture, hip or knee replacement, or spinal surgery in past 6 months Regular use of medications that influence study variables (growth/steroid hormones, estrogen, anti-inflammatory, beta blockers, etc.
Facility Information:
Facility Name
Wake Forest University
City
Winston-Salem
State/Province
North Carolina
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
34333991
Citation
Brinkley TE, Leng I, Bailey MJ, Houston DK, Hugenschmidt CE, Nicklas BJ, Hundley WG. Effects of Exercise and Weight Loss on Proximal Aortic Stiffness in Older Adults With Obesity. Circulation. 2021 Aug 31;144(9):684-693. doi: 10.1161/CIRCULATIONAHA.120.051943. Epub 2021 Aug 2.
Results Reference
derived

Learn more about this trial

Investigating Fitness Interventions in the Elderly (INFINITE)

We'll reach out to this number within 24 hrs